Transition Therapeutics Inc (NASDAQ:TTHI)

8.26
Delayed Data
As of Apr 24
 -0.04 / -0.48%
Today’s Change
4.36
Today|||52-Week Range
8.47
+20.81%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues29.6M0.0017.9M0.00
 
 
 
Depreciation And Amortization2.1M1.8M1.8M884.9K
 
 
 
 
 
 
Operating ExpensesGross Income---1.8M---884.9K
 
 
 
General Expenses14.4M10.7M10.6M20.0M
 
 
 
 
 
Research And Development8.0M6.4M7.0M15.6M
 
 
 
 
 
Total Operating Expenses16.5M12.6M12.4M20.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income13.1M-12.6M5.5M-20.9M
 
 
 
 
 
Extraordinary Credit0.000.000.002.7M
 
 
Extraordinary Charge--0.00-6.5M-2.9M
 
 
 
Other Expenses-452.2K170.4K905.8K258.4K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income12.9M-12.2M23.2K-20.6M
 
 
 
 
 
Income Taxes0.000.000.00-230.4K
 
 
Net Income12.9M-12.2M23.2K-20.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS23.1M25.4M26.8M30.1M
 
 
 
 
 
Shares To Calculate EPS Diluted23.1M25.4M26.8M30.1M
 
 
 
 
 
 
Earnings Per ShareEPS$0.56-$0.48$0.00-$0.67
 
 
 
 
EPS Diluted$0.56-$0.48$0.00-$0.67
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account